Improving long-term medication adherence for breast cancer survivors
SCH:INT: Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication
This study is all about helping breast cancer survivors stick to their long-term medication plans by understanding what makes it easier or harder for them to take their medicine, and it will use smart technology to offer personalized support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10465035 on NIH RePORTER |
What this research studies
This research focuses on enhancing medication adherence among breast cancer survivors who are prescribed long-term endocrine therapy. It aims to understand the various personal and environmental factors that influence medication-taking behavior. By utilizing a Multiscale Modeling and Intervention (MMI) system, the project will develop personalized interventions that consider cognitive, behavioral, and environmental influences on adherence. The approach includes using sensor-rich smartphones and monitoring systems to track medication events and provide tailored support to patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are survivors of hormone receptor-positive breast cancer who are prescribed long-term endocrine therapy.
Not a fit: Patients who are not on long-term endocrine therapy or those with non-hormone receptor-positive breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence, thereby reducing the risk of cancer recurrence in breast cancer survivors.
How similar studies have performed: Previous research has shown promise in using technology-driven interventions for medication adherence, but this approach aims to address gaps by considering a broader range of influencing factors.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Barnes, Laura Elizabeth — University of Virginia
- Study coordinator: Barnes, Laura Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.